EY Faraoni, BJ O'Brien, LN Strickland, BK Osborn… - Cancer immunology …, 2023 - AACR
Pancreatic ductal adenocarcinoma (PDAC) presents a 5-year overall survival rate of 11%,
despite efforts to improve clinical outcomes in the past two decades. Therapeutic resistance …